Wellington Management Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Buy |
531,551
+21,042
| +4% | +$65K | ﹤0.01% | 1616 |
|
|
2025
Q1 | $1.78M | Sell |
510,509
-2,793
| -0.5% | -$9.75K | ﹤0.01% | 1585 |
|
|
2024
Q4 | $1.68M | Buy |
513,302
+16,484
| +3% | +$53.9K | ﹤0.01% | 1599 |
|
|
2024
Q3 | $1.91M | Buy |
496,818
+21,807
| +5% | +$84K | ﹤0.01% | 1540 |
|
|
2024
Q2 | $1.47M | Buy |
475,011
+23,706
| +5% | +$73.3K | ﹤0.01% | 1578 |
|
|
2024
Q1 | $1.16M | Buy |
+451,305
| New | +$1.16M | ﹤0.01% | 1648 |
|
|
2023
Q2 | – | Sell |
-279,832
| Closed | -$848K | – | 1796 |
|
|
2023
Q1 | $848K | Sell |
279,832
-129,672
| -32% | -$393K | ﹤0.01% | 1699 |
|
|
2022
Q4 | $954K | Sell |
409,504
-24,060
| -6% | -$56.1K | ﹤0.01% | 1640 |
|
|
2022
Q3 | $828K | Sell |
433,564
-71,700
| -14% | -$137K | ﹤0.01% | 1693 |
|
|
2022
Q2 | $1.37M | Hold |
505,264
| – | – | ﹤0.01% | 1612 |
|
|
2022
Q1 | $1.51M | Buy |
505,264
+225,175
| +80% | +$671K | ﹤0.01% | 1658 |
|
|
2021
Q4 | $1.09M | Buy |
+280,089
| New | +$1.09M | ﹤0.01% | 1787 |
|